Lankler Douglas M's Form 4 filing
Pfizer Inc (PFE) · filed Nov 30, 2021
- Accession no.
- 0001225208-21-014220
- Filed
- Nov 30, 2021
- Trade date
- Nov 26, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 12 non-derivative transactions. Open-market sales total $2.17M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lankler Douglas MCIK 0001488270 | Officer (Executive Vice President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 26, 2021 | Common Stock | SSaleDisposed | −124 | $54.32 | −$6,735.68 | 106,193 | Direct | |
| Nov 26, 2021 | Common Stock | SSaleDisposed | −909 | $54.45 | −$49,495.05 | 105,284 | Direct | |
| Nov 26, 2021 | Common Stock | SSaleDisposed | −1,133 | $54.26 | −$61,476.58 | 104,151 | Direct | |
| Nov 26, 2021 | Common Stock | SSaleDisposed | −1,497 | $54.47 | −$81,541.59 | 102,654 | Direct | |
| Nov 26, 2021 | Common Stock | SSaleDisposed | −1,677 | $54.46 | −$91,329.42 | 100,977 | Direct | |
| Nov 26, 2021 | Common Stock | SSaleDisposed | −2,736 | $54.39 | −$148,811.04 | 98,241 | Direct | |
| Nov 26, 2021 | Common Stock | SSaleDisposed | −4,200 | $54.50 | −$228,900 | 94,041 | Direct | |
| Nov 26, 2021 | Common Stock | SSaleDisposed | −4,500 | $54.55 | −$245,475 | 89,541 | Direct | |
| Nov 26, 2021 | Common Stock | SSaleDisposed | −5,203 | $54.17 | −$281,846.51 | 84,338 | Direct | |
| Nov 26, 2021 | Common Stock | SSaleDisposed | −5,765 | $54.40 | −$313,616 | 78,573 | Direct | |
| Nov 26, 2021 | Common Stock | SSaleDisposed | −5,856 | $54.31 | −$318,039.36 | 72,717 | Direct | |
| Nov 26, 2021 | Common Stock | SSaleDisposed | −6,400 | $54.30 | −$347,520 | 66,317 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.